tiprankstipranks
Trending News
More News >
Rakovina Therapeutics Inc (TSE:RKV)
:RKV
Canadian Market

Rakovina Therapeutics Inc (RKV) Income Statement

Compare
22 Followers

Rakovina Therapeutics Inc Income Statement

Last quarter (Q3 2024), Rakovina Therapeutics Inc's total revenue was $―, a decrease of ― from the same quarter last year. In Q3, Rakovina Therapeutics Inc's net income was $-1.02M. See Rakovina Therapeutics Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ ―$ ―$ ―
Gross Profit
$ ―$ ―$ ―
Operating Expenses
$ ―$ ―$ ―
Depreciation and Amortization
$ 536.11K$ 536.11K$ ―
EBITDA
$ -1.93M$ -2.26M$ -5.11M
Operating Income
$ -2.48M$ -2.82M$ -2.47M
Other Income/Expenses
$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―
Net Income
$ -2.61M$ -2.79M$ -5.52M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―
Weighted Average Shares Outstanding
Weighted Average Shares Outstanding (Diluted)
Currency in USD

Rakovina Therapeutics Inc Earnings and Revenue History